Drug
Itolizumab Infusion
Itolizumab Infusion: highest development phase Phase 2, developed by Biocon. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Biocon
Trials
| Drug | Phase | Indication |
|---|---|---|
| Itolizumab IV infusion NCT04475588 | Phase 2 | Acute Respiratory Distress Syndrome |
Latest
No recent events.
Follow Itolizumab Infusion on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.